Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Cytokine-cytokine receptor interaction	10/295	9.689931765541306E-12	1.172481743630498E-9	0	0	34.53508771929825	875.8075359829744	CXCL10;CXCL9;TGFB1;TNFSF15;CXCR5;IL12B;IL12A;IL7R;IL12RB1;TNFRSF1A
Toll-like receptor signaling pathway	7/104	1.545411961576285E-10	9.349742367536524E-9	0	0	62.35365307037203	1408.6039666784584	CXCL10;CXCL9;CD80;IL12B;IRF5;IL12A;NFKB1
Toxoplasmosis	7/112	2.6143292311066597E-10	1.0544461232130194E-8	0	0	57.57971014492754	1270.4872858398405	TGFB1;NOS2;IL12B;IL12A;TYK2;NFKB1;TNFRSF1A
Inflammatory bowel disease	6/65	5.194995818965501E-10	1.571486235237064E-8	0	0	84.36864406779661	1803.6459593193324	TGFB1;STAT4;IL12B;IL12A;IL12RB1;NFKB1
Pathways in cancer	10/531	2.9807925250345286E-9	7.213517910583559E-8	0	0	18.66506717850288	366.4153639693561	TGFB1;NOS2;STAT4;IL12B;IL12A;IL7R;IL12RB1;HIF1A;NFKB1;NFE2L2
Th1 and Th2 cell differentiation	6/92	4.361842183804087E-9	8.796381737338242E-8	0	0	57.80232558139535	1112.7162323123707	STAT4;IL12B;IL12A;TYK2;IL12RB1;NFKB1
Chagas disease	6/102	8.152411672329653E-9	1.4092025890741258E-7	0	0	51.755208333333336	963.9382731709351	TGFB1;NOS2;IL12B;IL12A;NFKB1;TNFRSF1A
Leishmaniasis	5/77	9.798371169326721E-8	1.4820036393606666E-6	0	0	55.272222222222226	892.0088005526063	TGFB1;NOS2;IL12B;IL12A;NFKB1
JAK-STAT signaling pathway	6/162	1.3009718145048995E-7	1.7490843283899204E-6	0	0	31.753205128205128	503.4465629444726	STAT4;IL12B;IL12A;TYK2;IL7R;IL12RB1
Influenza A	6/172	1.8546202264175284E-7	2.244090473965209E-6	0	0	29.825301204819276	462.30456721802835	CXCL10;IL12B;IL12A;TYK2;NFKB1;TNFRSF1A
Tuberculosis	6/180	2.425774796033675E-7	2.668352275637043E-6	0	0	28.442528735632184	433.23502409208606	TGFB1;NOS2;IL12B;IL12A;NFKB1;TNFRSF1A
Amoebiasis	5/102	4.0243425709085886E-7	4.057878758999494E-6	0	0	40.97525773195876	603.3907496238485	TGFB1;NOS2;IL12B;IL12A;NFKB1
Th17 cell differentiation	5/107	5.109713367799578E-7	4.7559639807980694E-6	0	0	38.956862745098036	564.3662139323254	TGFB1;TYK2;IL12RB1;HIF1A;NFKB1
Coronavirus disease	6/232	1.074150937970815E-6	9.283733106747758E-6	0	0	21.84070796460177	300.1782541852689	CXCL10;IL12B;IL12A;TYK2;NFKB1;TNFRSF1A
RIG-I-like receptor signaling pathway	4/70	3.519721717082364E-6	2.839242185113107E-5	0	0	46.396270396270396	582.6039352777034	CXCL10;IL12B;IL12A;NFKB1
Pertussis	4/76	4.894372873939752E-6	3.7013694859169376E-5	0	0	42.51709401709402	519.874553049576	NOS2;IL12B;IL12A;NFKB1
Viral protein interaction with cytokine and cytokine receptor	4/100	1.4590163823584494E-5	1.0384763662668962E-4	0	0	31.849358974358974	354.6478025742392	CXCL10;CXCL9;CXCR5;TNFRSF1A
Lipid and atherosclerosis	5/215	1.5686484655908656E-5	1.0544803574249708E-4	0	0	18.81904761904762	208.18968635239386	IL12B;IL12A;NFKB1;TNFRSF1A;NFE2L2
Allograft rejection	3/38	2.47954657947373E-5	1.5790796637701123E-4	0	0	63.285714285714285	671.1354914711817	CD80;IL12B;IL12A
Type I diabetes mellitus	3/43	3.609024832058106E-5	2.1542838650966302E-4	0	0	55.361111111111114	566.3158139575121	CD80;IL12B;IL12A
Osteoclast differentiation	4/127	3.738839765870185E-5	2.1542838650966302E-4	0	0	24.82426516572858	253.06228583485418	TGFB1;TYK2;NFKB1;TNFRSF1A
Measles	4/139	5.320637647806756E-5	2.9263507062937157E-4	0	0	22.603988603988604	222.45336338757366	IL12B;IL12A;TYK2;NFKB1
Legionellosis	3/57	8.43655478823948E-5	4.3065593061325725E-4	0	0	40.97942386831276	384.4013976994155	IL12B;IL12A;NFKB1
Hepatitis C	4/157	8.541935813816672E-5	4.3065593061325725E-4	0	0	19.926596279537456	186.6711146472406	CXCL10;TYK2;NFKB1;TNFRSF1A
Hepatitis B	4/162	9.644487591248115E-5	4.6679319941640875E-4	0	0	19.29113924050633	178.37627031747488	TGFB1;STAT4;TYK2;NFKB1
Chemokine signaling pathway	4/192	1.8553291808050555E-4	8.481768908408482E-4	0	0	16.18821603927987	139.0936563491243	CXCL10;CXCL9;CXCR5;NFKB1
Kaposi sarcoma-associated herpesvirus infection	4/193	1.892626120058091E-4	8.481768908408482E-4	0	0	16.101750101750103	138.0302404443753	TYK2;HIF1A;NFKB1;TNFRSF1A
Bile secretion	3/90	3.276182586685581E-4	0.001415778903531983	0	0	25.393358876117496	203.7477152817502	ABCC2;ABCB4;SLC4A2
C-type lectin receptor signaling pathway	3/104	5.007043838450327E-4	0.002089145877422378	0	0	21.858085808580856	166.1104068879881	IL12B;IL12A;NFKB1
HIF-1 signaling pathway	3/109	5.743168995676725E-4	0.0023164114949229455	0	0	20.82180293501048	155.3791485414435	NOS2;HIF1A;NFKB1
TNF signaling pathway	3/112	6.216351196870161E-4	0.0024263822413589983	0	0	20.245667686034658	149.47694839317748	CXCL10;NFKB1;TNFRSF1A
Herpes simplex virus 1 infection	5/498	7.988365498237439E-4	0.0030206007040210316	0	0	7.901419878296146	56.3557252672223	IL12B;IL12A;TYK2;NFKB1;TNFRSF1A
Relaxin signaling pathway	3/129	9.37026120780873E-4	0.003435762442863201	0	0	17.499118165784832	122.01784063082127	TGFB1;NOS2;NFKB1
Fluid shear stress and atherosclerosis	3/139	0.001162465384462142	0.004137009162350564	0	0	16.204248366013072	109.49554471424038	NFKB1;TNFRSF1A;NFE2L2
African trypanosomiasis	2/37	0.0014020717242409484	0.004847162246661565	0	0	40.683673469387756	267.2837742480994	IL12B;IL12A
Non-alcoholic fatty liver disease	3/155	0.0015896437267174021	0.005342969192577935	0	0	14.486842105263158	93.3567650049236	TGFB1;NFKB1;TNFRSF1A
Necroptosis	3/159	0.001709849718117101	0.0055916706997883574	0	0	14.112535612535613	89.91590090262773	STAT4;TYK2;TNFRSF1A
ABC transporters	2/45	0.002068700520484921	0.0065871779731230375	0	0	33.10132890365448	204.59384020901297	ABCC2;ABCB4
Intestinal immune network for IgA production	2/48	0.002350495478973478	0.007292562896302329	0	0	30.937888198757765	187.27103230547277	TGFB1;CD80
Malaria	2/50	0.002547877166796628	0.0077073284295598	0	0	29.645833333333332	177.0595839464994	TGFB1;IL12A
Epstein-Barr virus infection	3/202	0.0033710306786318804	0.00994865151498677	0	0	11.039084310441094	62.84039303544849	CXCL10;TYK2;NFKB1
Proteoglycans in cancer	3/205	0.003513608535328855	0.010122538875590273	0	0	10.873487348734873	61.44729154215966	TGFB1;IL12B;HIF1A
Cytosolic DNA-sensing pathway	2/63	0.004013249341598154	0.011293096984497132	0	0	23.31264637002342	128.64277412661008	CXCL10;NFKB1
Human T-cell leukemia virus 1 infection	3/219	0.00422778405020718	0.011626406138069744	0	0	10.161522633744855	55.54366808375858	TGFB1;NFKB1;TNFRSF1A
Adipocytokine signaling pathway	2/69	0.004794036255489164	0.012610399715525846	0	0	21.218550106609808	113.31517536894962	NFKB1;TNFRSF1A
Renal cell carcinoma	2/69	0.004794036255489164	0.012610399715525846	0	0	21.218550106609808	113.31517536894962	TGFB1;HIF1A
Chronic myeloid leukemia	2/76	0.005786228730415143	0.014586118257921507	0	0	19.204633204633204	98.94754273926414	TGFB1;NFKB1
Pancreatic cancer	2/76	0.005786228730415143	0.014586118257921507	0	0	19.204633204633204	98.94754273926414	TGFB1;NFKB1
PD-L1 expression and PD-1 checkpoint pathway in cancer	2/89	0.007855172466354438	0.019397466702630345	0	0	16.324302134646963	79.11708604949641	HIF1A;NFKB1
Small cell lung cancer	2/92	0.008373448487098152	0.020263745338777527	0	0	15.777777777777779	75.46021169623046	NOS2;NFKB1
Rheumatoid arthritis	2/93	0.008549551592924202	0.02028423024987899	0	0	15.603610675039246	74.30246609423192	TGFB1;CD80
IL-17 signaling pathway	2/94	0.008727318488466829	0.020307798790470892	0	0	15.433229813664596	73.17352801930804	CXCL10;NFKB1
MAPK signaling pathway	3/294	0.009519387880313554	0.021732942141847927	0	0	7.5139366170294	34.97305241395518	TGFB1;NFKB1;TNFRSF1A
AGE-RAGE signaling pathway in diabetic complications	2/100	0.009828577820710147	0.02202329474640607	0	0	14.48396501457726	66.95156387938638	TGFB1;NFKB1
NF-kappa B signaling pathway	2/104	0.010595391852093367	0.02330986207460541	0	0	13.913165266106443	63.26783872604579	NFKB1;TNFRSF1A
Insulin resistance	2/108	0.01138794860238534	0.024606103230154035	0	0	13.38544474393531	59.90253727027526	NFKB1;TNFRSF1A
Human papillomavirus infection	3/331	0.01310473738950457	0.0278188284935097	0	0	6.653794037940379	28.842743176459503	TYK2;NFKB1;TNFRSF1A
Sphingolipid signaling pathway	2/119	0.013697658666623409	0.02857614997692125	0	0	12.12026862026862	52.00238049873368	NFKB1;TNFRSF1A
FoxO signaling pathway	2/131	0.016429116348176096	0.03369361149371708	0	0	10.986157253599114	45.13882574929996	TGFB1;IL7R
Alzheimer disease	3/369	0.017494316345323863	0.03528020462973645	0	0	5.951426836672739	24.0787542337412	NOS2;NFKB1;TNFRSF1A
Apoptosis	2/142	0.019120312299200925	0.037927176855792	0	0	10.11734693877551	40.03438268908486	NFKB1;TNFRSF1A
Cellular senescence	2/156	0.022794732213180412	0.04448649351281984	0	0	9.191094619666048	34.7536042255875	TGFB1;NFKB1
Hepatocellular carcinoma	2/168	0.026157807067230678	0.05023959770055416	0	0	8.521514629948365	31.049055329541552	TGFB1;NFE2L2
NOD-like receptor signaling pathway	2/181	0.030014385830831856	0.05674594821141648	0	0	7.897446129289705	27.68906595689205	TYK2;NFKB1
Arginine biosynthesis	1/22	0.03250201526892278	0.0605037515006101	0	0	32.756978653530375	112.24025378249362	NOS2
Pathways of neurodegeneration	3/475	0.03362765195318297	0.061650695247502114	0	0	4.589924670433145	15.570890633825456	NOS2;NFKB1;TNFRSF1A
Pathogenic Escherichia coli infection	2/197	0.0350519541056609	0.06330278278783535	0	0	7.243589743589744	24.27271810304722	NFKB1;TNFRSF1A
Diabetic cardiomyopathy	2/203	0.037020646417589724	0.06587497377247582	0	0	7.025230987917555	23.157124963281667	TGFB1;NFKB1
Human immunodeficiency virus 1 infection	2/212	0.040052282579158924	0.07023661147939464	0	0	6.72108843537415	21.625569921688047	NFKB1;TNFRSF1A
Human cytomegalovirus infection	2/225	0.04459256228877601	0.07708142909916997	0	0	6.325112107623318	19.67228903251222	NFKB1;TNFRSF1A
Shigellosis	2/246	0.05230977958026773	0.08914765252411824	0	0	5.774590163934426	17.038343675733206	NFKB1;TNFRSF1A
Salmonella infection	2/249	0.05344919094427219	0.08982433478134631	0	0	5.7035858877964145	16.705938686983604	NFKB1;TNFRSF1A
Primary immunodeficiency	1/38	0.05549603883191679	0.09198658491317714	0	0	18.576887232059647	53.71402231134463	IL7R
Graft-versus-host disease	1/42	0.0611614760831625	0.10000727846030624	0	0	16.761143818334734	46.83462101550951	CD80
Cocaine addiction	1/49	0.07099704156206502	0.11454189372013156	0	0	14.311781609195402	37.85633785017516	NFKB1
Arginine and proline metabolism	1/50	0.0723939657090184	0.11525881382620035	0	0	14.019000703729768	36.80874147674154	NOS2
Autoimmune thyroid disease	1/53	0.07657256603469816	0.12032831805452567	0	0	13.208222811671087	33.938745289872976	CD80
Viral myocarditis	1/60	0.08625199387573851	0.13380116998672256	0	0	11.637054354178844	28.516393460743195	CD80
Acute myeloid leukemia	1/67	0.09583330995635121	0.14391767708148792	0	0	10.399164054336469	24.387547080252187	NFKB1
Mitophagy	1/68	0.09719411637551117	0.14391767708148792	0	0	10.243437982501286	23.87791592101611	HIF1A
PI3K-Akt signaling pathway	2/354	0.09830377799017932	0.14391767708148792	0	0	3.980925324675325	9.234523889819737	IL7R;NFKB1
Central carbon metabolism in cancer	1/70	0.09990979235409078	0.14391767708148792	0	0	9.945527236381809	22.909398431433704	HIF1A
Epithelial cell signaling in Helicobacter pylori infection	1/70	0.09990979235409078	0.14391767708148792	0	0	9.945527236381809	22.909398431433704	NFKB1
Prolactin signaling pathway	1/70	0.09990979235409078	0.14391767708148792	0	0	9.945527236381809	22.909398431433704	NFKB1
Amyotrophic lateral sclerosis	2/364	0.10300765845342483	0.1466344314454636	0	0	3.8689818468823995	8.79400979314804	NOS2;TNFRSF1A
Thyroid hormone synthesis	1/75	0.10666448008193466	0.15007444290597785	0	0	9.271202236719478	20.749572437350395	ALB
Gastric acid secretion	1/76	0.10800952509913052	0.1502201441033884	0	0	9.14712643678161	20.3572579045293	SLC4A2
B cell receptor signaling pathway	1/81	0.11470543902882316	0.15771997866463183	0	0	8.573275862068966	18.564467269525416	NFKB1
Peroxisome	1/82	0.11603877878724199	0.15776058689052	0	0	8.46700723712218	18.236501342427736	NOS2
Colorectal cancer	1/86	0.12135275220631468	0.1631520335218231	0	0	8.066937119675456	17.0136033150249	TGFB1
Hypertrophic cardiomyopathy	1/90	0.12663583920182195	0.16838391805956543	0	0	7.702828361100349	15.917430476118055	TGFB1
Salivary secretion	1/93	0.130577989553445	0.17159649235458868	0	0	7.450524737631184	15.167663594496686	SLC4A2
TGF-beta signaling pathway	1/94	0.13188821313203924	0.17159649235458868	0	0	7.370040786058584	14.930232938854378	TGFB1
Dilated cardiomyopathy	1/96	0.13450293659933887	0.1726567123249727	0	0	7.214156079854809	14.472818068487964	TGFB1
Prostate cancer	1/97	0.135807441882233	0.1726567123249727	0	0	7.1386494252873565	14.2524368267114	NFKB1
Choline metabolism in cancer	1/98	0.13711004640271124	0.1726567123249727	0	0	7.064699608958407	14.037356193959155	HIF1A
Hematopoietic cell lineage	1/99	0.13841075285555662	0.1726567123249727	0	0	6.992258972554539	13.82739870293458	IL7R
Longevity regulating pathway	1/102	0.14230151047491377	0.17392406835822796	0	0	6.7835438716285426	13.226602405790088	NFKB1
Pancreatic secretion	1/102	0.14230151047491377	0.17392406835822796	0	0	6.7835438716285426	13.226602405790088	SLC4A2
T cell receptor signaling pathway	1/104	0.1448859074147043	0.1753119479717922	0	0	6.651155005021761	12.848759048563156	NFKB1
Neurotrophin signaling pathway	1/119	0.16403037337016033	0.1965116354236574	0	0	5.801285797779077	10.487005597367974	NFKB1
Thyroid hormone signaling pathway	1/121	0.166551449837356	0.19757573951294194	0	0	5.704022988505747	10.224181762604308	HIF1A
Cell cycle	1/124	0.17031928931456847	0.20008382531128915	0	0	5.5640594336977856	9.848832720808518	TGFB1
Systemic lupus erythematosus	1/135	0.18399433327201103	0.21085345113523035	0	0	5.104477611940299	8.641116555141592	CD80
Apelin signaling pathway	1/137	0.18645718406173262	0.21085345113523035	0	0	5.028904665314402	8.446315147566118	NOS2
Autophagy	1/137	0.18645718406173262	0.21085345113523035	0	0	5.028904665314402	8.446315147566118	HIF1A
Yersinia infection	1/137	0.18645718406173262	0.21085345113523035	0	0	5.028904665314402	8.446315147566118	NFKB1
Cell adhesion molecules	1/148	0.19987495053362248	0.22322178130455575	0	0	4.650011728829463	7.486813486371484	CD80
Gastric cancer	1/149	0.20108408398509567	0.22322178130455575	0	0	4.618359739049394	7.4079974098596075	TGFB1
mTOR signaling pathway	1/154	0.20710330503717117	0.2278136355408883	0	0	4.466306062654947	7.032366614617934	TNFRSF1A
Hippo signaling pathway	1/163	0.21782760935328782	0.23745171830403447	0	0	4.216262239250745	6.425799996664095	TGFB1
Protein processing in endoplasmic reticulum	1/171	0.22724250341901603	0.24550306172947267	0	0	4.016227180527383	5.9509945613654756	NFE2L2
Neutrophil extracellular trap formation	1/189	0.24802719422198705	0.26558664160053486	0	0	3.628393250183419	5.058767133765583	NFKB1
Transcriptional misregulation in cancer	1/192	0.25143835105253676	0.26687754804699076	0	0	3.570861166275501	4.929778966484762	NFKB1
Viral carcinogenesis	1/203	0.2638184122405329	0.2775828511400389	0	0	3.374530556503926	4.496542545859288	NFKB1
cAMP signaling pathway	1/216	0.27819431969350883	0.29018545416305663	0	0	3.1684041700080194	4.053768512915731	NFKB1
Ras signaling pathway	1/232	0.2955154938047619	0.3056185876100529	0	0	2.9465591879384982	3.5919558655424773	NFKB1
Chemical carcinogenesis	1/239	0.3029665219521898	0.3091343750687166	0	0	2.858881483627934	3.4138846317300957	NFKB1
Calcium signaling pathway	1/240	0.30402471597667174	0.3091343750687166	0	0	2.846775357091329	3.3895024841508117	NOS2
Parkinson disease	1/249	0.3134788398667338	0.3160911635322899	0	0	2.742213570634038	3.1810319580645494	NFE2L2
MicroRNAs in cancer	1/310	0.37436196088314105	0.37436196088314105	0	0	2.1940631625934603	2.1557375738800304	NFKB1
